Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Pediatric Resective Epilepsy Surgery ====== ===== Outcome ===== [[Pediatric Resective Epilepsy Surgery Outcome]]. ===== Case series ===== Parker et al. performed a [[retrospective]] analysis of 376 pediatric patients who underwent [[resective epilepsy surgery]] between 2007 and 2016 in [[Stanford]] using the Truven MarketScan database. Filled [[Anticonvulsant]] prescriptions during the pre-and [[postoperative]] periods were compared. [[Univariate]] and [[multivariate]] analyses identified factors associated with achieving stable discontinuation of or reduction in the number of [[anticonvulsant]]s. Health care utilization and costs were systematically compared. One hundred seventy-one patients (45.5%) achieved a >90-day ASD-free period after surgery, and 84 (22.3%) additional patients achieved a stable reduction in the number of ASDs. Achieving ASD freedom was more common in patients undergoing total hemispherectomy (n = 21, p = .002), and less common in patients with tuberous sclerosis (p = .003). A higher number of preoperative ASDs was associated with a greater likelihood of achieving ASD reduction postoperatively (hazard ratio [HR]: 1.85, 95% confidence interval [CI]: 1.50-2.28), but was not associated with a significant difference in the likelihood of achieving ASD freedom (0.83, 95% CI: 0.49-1.39). Achieving an ASD-free period was associated with fewer hospital readmissions within the first year after surgery. Patterns of [[anticonvulsant]] use and discontinuation after [[pediatric epilepsy surgery]] provide an unbiased surgical outcome endpoint extractable from administrative databases, where changes in seizure frequency are not captured. This [[quantitative]] measure can augment traditional surgical [[outcome]] [[scale]]s, incorporating a significant clinical parameter associated with improved [[quality of life]] ((Parker JJ, Zhang Y, Fatemi P, Halpern CH, Porter BE, Grant GA. Antiseizure medication use and medical resource utilization after resective [[epilepsy surgery]] in [[child]]ren in the [[United States]]: A contemporary nationwide cross-sectional cohort analysis. Epilepsia. 2022 Feb 25. doi: 10.1111/epi.17180. Epub ahead of print. PMID: 35213744.)). pediatric_resective_epilepsy_surgery.txt Last modified: 2024/06/07 02:49by 127.0.0.1